India has tremendous potential for innovation in healthcare products. This is yet to be fully realized because of the lack of strong coupling mechanisms that match pull forces based on clinical need and push forces based on research output. The CANDO-ETR grants aim to provide bridge funding to enable the transition from early translational research towards clinical application.
They will fund Early Translational Research, defined in this context as research done to prove at a laboratory level any idea/hypothesis/principle related to a human healthcare intervention (therapeutic, vaccine or diagnostic). The idea/experiments proposed should have a clear connection with a potential clinical application and should be robust enough to eliminate confounding interpretations or obvious downsides that can prevent development for clinical use.
Since this Grant is governed by Government CSR funding rules, we have to restrict eligibility for funding to full time faculty at Government research institutions/universities.
The idea/hypothesis/principle espoused in the proposal should have plausibility based on prior data (preferably from the proposers laboratory).
The proposer should have access to needed animal models/instrumentation for carrying out the experiments proposed.